Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Status: Publicly traded
Direct answer
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. is publicly traded on SHH under the ticker 603707.SS.
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium besylate, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix...
Can you invest in Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.?
Yes. Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. trades publicly on SHH as 603707.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Detailed equity research is provided by MarketSnap.